Advertisment

New IT DNA at Genomics England

Applying analytics for improving capability and capacity to process samples and interpret findings

author-image
Pratima Harigunani
New Update
ID

PUNE, INDIA: Genomics England, a wholly owned company of the Department of Health, is working on new ways to help design and implement the IT operating environment for the 100,000 Genomes Project. It has selected Cognizant as part of this goal.

Advertisment

The 100,000 Genomes Project aims to enable new scientific discovery, medical insights and diagnostics. As part of a two-year agreement, Cognizant will help provide end-to-end systems integration and analytics services for the technology  platform built by Genomics England. This will enable Genomics England to augment its capability and capacity to process samples and interpret findings. An improved technology backbone supported by advanced analytics will also help Genomics England optimise its business processes and simplify the management and analysis of clinical, laboratory and health data, as per the announcement.

David Brown, Head of Informatics Infrastructure, Genomics England, said: “We selected Cognizant for its extensive life sciences capabilities, knowledge of research, management and analysis of clinical data sets, and experience in working with the UK public sector organisations.”

Bhaskar Sambasivan, Vice President of Cognizant’s Life Sciences practice, said: “Our culture of investing in understanding our customers’ businesses, deep programme management expertise in the healthcare and life sciences industry, and robust system integration and business analytics capabilities enable us to deliver a broad range of solutions for Genomics England as it creates genome sequences and clinical data at an unprecedented scale.”

analytics